Research Correspondence

DOI: 10.4244/EIJ-D-24-00599

Outcomes of high-risk PCI assisted by VA-ECMO with local anaesthesia

Alexander M. Griffioen1, MD; Marleen H. van Wely1, MD; Lokien X. van Nunen1, MD, PhD; Stijn C.H. van den Oord2, MD, PhD; Herbert B. van Wetten1, MD; Sytse F. de Jong1, MSc; Peter Damman1, MD, PhD; Niels van Royen1, MD, PhD; Robert Jan M. van Geuns1, MD, PhD

High-risk percutaneous coronary intervention (PCI) is increasingly performed because of an ageing population with a high incidence of comorbidities and high surgical risk scores1. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an effective method to prevent haemodynamic deterioration during high-risk PCI. VA-ECMO is mainly surgically deployed under general anaesthesia. New developments have facilitated a completely percutaneous insertion of VA-ECMO with local anaesthesia, reducing operating team sizes and enabling early mobilisation after PCI without the need for intensive care unit (ICU) admission.

This study is a single-centre registry that included all patients undergoing high-risk PCI with VA-ECMO support between January 2020 and March 2024 at the Radboud University Medical Center in Nijmegen, the Netherlands. The study design has been previously described in detail2. Preprocedural angiographic computed tomography (CT) scans were performed in all cases to assess peripheral access. The procedural set-up for VA-ECMO (de)cannulation was similar for all cases (Supplementary Figure 1, Moving image 1).

Procedural success was defined as successful revascularisation (final residual stenosis <50% with a Thrombolysis in Myocardial Infarction flow grade 3, achieved in at...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 7
Apr 7, 2025
Volume 21 Number 7
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00029 Aug 21, 2023
VA-ECMO in cardiogenic shock: is the road closed or open?
Thiele H and Freund A
free

Research Correspondence

10.4244/EIJ-D-23-01046 Apr 15, 2024
Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock
Giustino G et al
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved